Biora Therapeutics Net Profit Margin Over Time
| BIOR Stock | USD 1.67 0.04 2.45% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Biora Therapeutics Performance and Biora Therapeutics Correlation. Biora |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biora Therapeutics. If investors know Biora will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biora Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.36 | Revenue Per Share 0.329 | Quarterly Revenue Growth 158 | Return On Assets (1.25) |
The market value of Biora Therapeutics is measured differently than its book value, which is the value of Biora that is recorded on the company's balance sheet. Investors also form their own opinion of Biora Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Biora Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biora Therapeutics' market value can be influenced by many factors that don't directly affect Biora Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biora Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Biora Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biora Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Profit Margin Analysis
Compare Biora Therapeutics and related stocks such as Eliem Therapeutics, HCW Biologics, and Scpharmaceuticals Net Profit Margin Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HCWB | (1.4098) | (1.4098) | (1.4098) | (1.4098) | (1.4098) | (1.4098) | (1.4098) | (1.4098) | (1.4098) | (1.4098) | (1.4098) | (2.1902) | (2.1902) | (8.7952) | (9.24) |
| SCPH | (4.0322) | (4.0322) | (4.0322) | (4.0322) | (4.0322) | (4.0322) | (4.0322) | (4.0322) | (4.0322) | (4.0322) | (4.0322) | (4.0322) | (4.0322) | (3.63) | (3.81) |
| MIST | (2.8422) | (2.8422) | (2.8422) | (2.8422) | (2.8422) | (2.8422) | (2.8422) | (2.8422) | (2.8422) | (2.8422) | (2.8422) | (2.8422) | (11.4268) | (59.685) | (56.7) |
| MCRB | (4.2074) | (4.2074) | (4.2074) | (4.2074) | (4.2074) | (4.2074) | (4.2074) | (2.7844) | (3.5003) | (1.8619) | (2.6029) | (0.4243) | (35.6094) | (0.9002) | (0.95) |
| LUMO | (14.4739) | (9.6619) | (13.8239) | (28.527) | 0.6198 | (1.1173) | (24.1506) | (184) | (44.4403) | (45.9284) | (33.7083) | (132) | (20.3953) | (16.5939) | (17.42) |
Biora Therapeutics and related stocks such as Eliem Therapeutics, HCW Biologics, and Scpharmaceuticals Net Profit Margin description
The percentage of revenue left after all expenses have been deducted from sales. The measure is calculated by dividing net profit by revenue.My Equities
My Current Equities and Potential Positions
| Biora Therapeutics | BIOR |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
USD 1.67
Additional Tools for Biora Stock Analysis
When running Biora Therapeutics' price analysis, check to measure Biora Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biora Therapeutics is operating at the current time. Most of Biora Therapeutics' value examination focuses on studying past and present price action to predict the probability of Biora Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biora Therapeutics' price. Additionally, you may evaluate how the addition of Biora Therapeutics to your portfolios can decrease your overall portfolio volatility.